Mergers: Commission starts investigation for possible breach of the standstill obligation in Illumina / GRAIL transaction* The European Commission has decided to open an investigation to assess whether Illumina's decision to complete its acquisition of GRAIL, while the Commission's in-depth investigation into the proposed transaction is still ongoing, constitutes a breach of the “standstill obligation” under Article 7 of the Merger Regulation. The standstill obligation prevents the potentially irreparable negative impact
The EU Commission starts an investigation for possible breach of a standstill obligation in a merger between two biotechnology and pharmaceutical companies (Illumina / GRAIL)
Access to this article is restricted to subscribers
Already Subscribed? Sign-in
Access to this article is restricted to subscribers.
Read one article for free
Sign-up to read this article for free and discover our services.